ABOUT CAMELYN

About the Company

"Camelyn LTD" started activities in 2004. "Camelyn" is a privately owned Georgian Scientific-Pharmaceutical Company.
The company is dedicated to identifying and developing immunomodulatory activity, antitumoral, antibacterial, and antivirus treatment products. As well as identifying and developing biologically active compounds for use in the food industry and cosmetology.

"Camelyn" in the USA

Camelyn’s branch office in the USA was established in January 2007. "Camelyn US, Inc" takes on the promotion of our products and the representation of our company in South and North America and other countries too. "Camelyn US, Inc" manages our extensive network of promotion agents in various countries.

Research & Development
The Company is dedicated to identifying and developing biologically active natural compounds for use in medicine, the food industry, and cosmetology. The company identifies Research and Development as one of the most critical areas leading to the company's success. Apart from employing well-qualified technical staff company have collaboration activity with a number of universities and research centers not only in Georgia but in the US of America, Canada, and Europe. This makes it possible for "Camelyn" to stay on top of the new developments in the field and to assist in the discovery of new chemical entities in the fields of the tumor and other infectious diseases.

Clinical Trials Overview
The therapeutic properties of Camelin have been studied by us since 1946.
Preclinical, Clinical, and Double-blind Research with Camelyn's products (Camelyn M1, Camelyn M2, Camelyn M3, Camelyn M4 ) were performed in several Clinical Center of Moskow, Leningrad, Kharkiv, and Tbilisi with very promising results.